• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普鲁卡因酰胺在先天性因子XI缺乏患者中诱导产生循环抗凝物质。

Procainamide-induced circulating anticoagulants in a congenitally-deficient factor XI patient.

作者信息

Clyne L P, Farber L R, Chopyk R L

机构信息

Department of Clinical Laboratories, Yale New Haven Hospital, Connecticut.

出版信息

Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116(2):239-44.

PMID:2475403
Abstract

A 70 year old male patient admitted for coronary bypass surgery presented with a procainamide-induced lupus syndrome. This syndrome included a LLAC with a positive IgM ACA titer as well as a factor XII inhibitor. These drug-induced inhibitors were superimposed upon the patient's congenital deficiency of factor XI. The methods used to identify these abnormalities are described together with the replacement therapy employed to cover the surgical procedure. The long-term withdrawal of procainamide was associated with correction of all coagulation abnormalities except the factor XI deficiency.

摘要

一名因冠状动脉搭桥手术入院的70岁男性患者出现了普鲁卡因胺诱发的狼疮综合征。该综合征包括抗心磷脂抗体(IgM ACA)滴度阳性的狼疮抗凝物(LLAC)以及因子Ⅻ抑制剂。这些药物诱发的抑制剂叠加在患者先天性因子Ⅺ缺乏的基础上。文中描述了用于识别这些异常的方法以及为覆盖手术过程所采用的替代疗法。长期停用普鲁卡因胺后,除因子Ⅺ缺乏外,所有凝血异常均得到纠正。

相似文献

1
Procainamide-induced circulating anticoagulants in a congenitally-deficient factor XI patient.普鲁卡因酰胺在先天性因子XI缺乏患者中诱导产生循环抗凝物质。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116(2):239-44.
2
Acquired factor XI deficiency in systemic lupus erythematosus.
Thromb Haemost. 1982 Dec 27;48(3):250-2.
3
Studies on a circulating anticoagulant in procainamide-induced lupus erythematosus.关于普鲁卡因胺诱发的红斑狼疮中一种循环抗凝物质的研究。
Arch Intern Med. 1981 Nov;141(12):1688-90.
4
Circulating anticoagulant in the procainamide-induced lupus syndrome.普鲁卡因胺诱发的狼疮综合征中的循环抗凝物质。
Arch Intern Med. 1977 Oct;137(10):1471-3.
5
Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies.与普鲁卡因胺诱导的狼疮综合征及抗心磷脂抗体相关的肺血栓栓塞症
Ann Rheum Dis. 1989 Mar;48(3):232-5. doi: 10.1136/ard.48.3.232.
6
Cofactor of the "lupus anticoagulant".“狼疮抗凝物”的辅助因子
Thromb Diath Haemorrh. 1974 Dec 31;32(2-3):554-63.
7
[Procainamide-induced lupus in a patient with bilateral pleural effusion].
Nihon Kokyuki Gakkai Zasshi. 1998 Jun;36(6):535-40.
8
The lupus inhibitor: a study of its heterogeneity.狼疮抑制剂:对其异质性的一项研究。
Thromb Haemost. 1981 Dec 23;46(4):734-9.
9
Procainamide-induced lupus.普鲁卡因胺诱发的狼疮。
Johns Hopkins Med J. 1976 Jun;138(6):289-95.
10
Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulants.
Thromb Haemost. 1984 Jul 29;51(3):317-20.

引用本文的文献

1
Drug-induced lupus anticoagulants and antiphospholipid antibodies.药物诱导性狼疮抗凝物和抗磷脂抗体。
Curr Rheumatol Rep. 2012 Feb;14(1):71-8. doi: 10.1007/s11926-011-0227-1.